Y63.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Failure in dosage during unsp surgical and medical care The 2022 edition of ICD-10-CM Y63.9 became effective on October 1, 2021.
Encounter for therapeutic drug level monitoring. Z51.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM Z51.81 became effective on October 1, 2018. This is the American ICD-10-CM version of Z51.81 - other international versions of ICD-10 Z51.81 may differ.
Code annotations containing back-references to Z51.81: Code Also: Z79 ICD-10-CM Diagnosis Code Z79. Long term (current) drug therapy 2016 2017 2018 2019 Non-Billable/Non-Specific Code. Code Also any therapeutic drug level monitoring (Z51.81) Includes long term (current) drug use for prophylactic purposes.
The occurrence of drug toxicity is classified in ICD-10-CM as follows: When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug (T36-T50).
Failure in dosage during unspecified surgical and medical care 1 Y63.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 Short description: Failure in dosage during unsp surgical and medical care 3 The 2021 edition of ICD-10-CM Y63.9 became effective on October 1, 2020. 4 This is the American ICD-10-CM version of Y63.9 - other international versions of ICD-10 Y63.9 may differ.
Y63.9 describes the circumstance causing an injury, not the nature of the injury. This chapter permits the classification of environmental events and circumstances as the cause of injury, and other adverse effects. Where a code from this section is applicable, it is intended that it shall be used secondary to a code from another chapter ...
If the same code would describe the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, assign the code only once.
Underdosing refers to taking less of a medication than is prescribed by a provider or a manufacturer's instruction . Discontinuing the use of a prescribed medication on the patient's own initiative (not directed by the patient's provider) is also classified as an underdosing. For underdosing, assign the code from categories T36 - T50 (fifth or sixth character “6”).
Codes in categories T36 - T65 are combination codes that include the substance that was taken as well as the intent. No additional external cause code is required for poisonings, toxic effects, adverse effects and underdosing codes. Use as many codes as necessary to describe completely all drugs, medicinal or biological substances.
When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36 - T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined. If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code (s) for all manifestations of poisonings.
Nonprescribed drug taken with correctly prescribed and properly administered drug. If a nonprescribed drug or medicinal agent was taken in combination with a correctly prescribed and properly administered drug, any drug toxicity or other reaction resulting from the interaction of the two drugs would be classified as a poisoning.
Codes for underdosing should never be assigned as principal or first-listed codes. If a patient has a relapse or exacerbation of the medical condition for which the drug is prescribed because of the reduction in dose, then the medical condition itself should be coded.
These changes include: If the patient is treated with oral hypoglycemic medication and insulin, only assign the Z79.4 for long- term use of insulin , which is not a change for 2021. If the patient is treated with both insulin and injectable non-insulin anti-diabetic drug, assign Z79.4 and Z79.899 (other long-term drug therapy).
There was a Coding Clinic edition published in the first quarter of 2020 that cited a patient with a history of type 2 diabetic neuropathy and bariatric surgery. The physician documented that the patient’s diabetes had resolved after the bariatric surgery.
If the patient is treated with both oral hypoglycemic medications and injectable non-insulin anti-diabetic drug, assign Z79.84 (long-term use of oral hypoglycemic drugs) and Z79.899. In 2020, the Official Coding and Reporting Guidelines indicated that if the patient was treated with insulin and oral hypoglycemic drugs, assign only Z79.84.